Ethyl 1,2,3,4-tetrahydro-1-(2-thienyl)-2-isoquinolinecarboxylate | 180272-34-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四氢异喹啉
• 英文名称: Ethyl 1,2,3,4-tetrahydro-1-(2-thienyl)-2-isoquinolinecarboxylate
• 英文别名: Ethyl 1-(2-thienyl)-1,2,3,4-tetrahydro-2-isoquinolinecarboxylate；ethyl 1-thiophen-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxylate
• CAS: 180272-34-8
• 化学式: C₁₆H₁₇NO₂S
• 分子量: 287.382
• InChiKey: BYCDIILVONDENH-UHFFFAOYSA-N

物化性质

• 沸点：
  418.1±45.0 °C(Predicted)
• 密度：
  1.222±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  57.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  Ethyl 1,2,3,4-tetrahydro-1-(2-thienyl)-2-isoquinolinecarboxylate 生成 3-Quinuclidinyl 1,2,3,4-tetrahydro-1-(2-thienyl)-2-isoquinolinecarboxylate monooxalate
  参考文献：
  名称：

  Quinuclidine derivatives and medicinal composition thereof

  摘要：

  由下列通用式（I）表示的喹诺啉衍生物，其盐、N-氧化物或季铵盐，以及含有这些物质的药物组合物。该化合物对毛细血管M.sub.3受体具有拮抗作用，并可用作预防或治疗泌尿系统疾病、呼吸系统疾病或消化系统疾病的药物。

  公开号：

  US06017927A1
• 作为产物：
  描述：

  N-phenethylthiophene-2-carboxamide 在 sodium tetrahydroborate 、 phosphorus pentoxide 、 potassium carbonate 、 三氯氧磷 作用下， 以 乙醇 、 二氯甲烷 、 xylene 为溶剂， 反应 62.5h， 生成 Ethyl 1,2,3,4-tetrahydro-1-(2-thienyl)-2-isoquinolinecarboxylate
  参考文献：
  名称：

  Synthesis and Antimuscarinic Properties of Quinuclidin-3-yl 1,2,3,4-Tetrahydroisoquinoline-2-carboxylate Derivatives as Novel Muscarinic Receptor Antagonists

  摘要：

  In the course of continuing efforts to develop potent and bladder-selective muscarinic M-3 receptor antagonists, quinuclidin-3-yl 1-aryl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives and related compounds were designed as conformationally restricted analogues of quinuclidin-3-yl benzhydrylcarbamate (8). Binding assays with rat muscarinic receptor subtypes revealed that the quinuclidin-3-yl 1-aryl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives showed high affinities for the M3 receptor, and selectivity for the M3 receptor over the M-2 receptor. Of these derivatives, (+)-(1S,3'R)-quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monohydrochloride (9b) exhibited almost the same inhibitory activity against bladder contraction to that of oxybutynin (1), and more than 10-fold selectivity for bladder contraction versus salivary secretion, demonstrating that 9b may be useful for the treatment of symptoms associated with overactive bladder without having side effects such as dry mouth.

  DOI：

  10.1021/jm050099q

文献信息

• NOVEL QUINUCLIDINE DERIVATIVES AND MEDICINAL COMPOSITION THEREOF
  申请人：YAMANOUCHI PHARMACEUTICAL CO. LTD.

  公开号：EP0801067B1

  公开（公告）日：2003-03-05
• US6017927A
  申请人：——

  公开号：US6017927A

  公开（公告）日：2000-01-25
• US6174896B1
  申请人：——

  公开号：US6174896B1

  公开（公告）日：2001-01-16
• Synthesis and Antimuscarinic Properties of Quinuclidin-3-yl 1,2,3,4-Tetrahydroisoquinoline-2-carboxylate Derivatives as Novel Muscarinic Receptor Antagonists
  作者：Ryo Naito、Yasuhiro Yonetoku、Yoshinori Okamoto、Akira Toyoshima、Ken Ikeda、Makoto Takeuchi

  DOI：10.1021/jm050099q

  日期：2005.10.1

  In the course of continuing efforts to develop potent and bladder-selective muscarinic M-3 receptor antagonists, quinuclidin-3-yl 1-aryl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives and related compounds were designed as conformationally restricted analogues of quinuclidin-3-yl benzhydrylcarbamate (8). Binding assays with rat muscarinic receptor subtypes revealed that the quinuclidin-3-yl 1-aryl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives showed high affinities for the M3 receptor, and selectivity for the M3 receptor over the M-2 receptor. Of these derivatives, (+)-(1S,3'R)-quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monohydrochloride (9b) exhibited almost the same inhibitory activity against bladder contraction to that of oxybutynin (1), and more than 10-fold selectivity for bladder contraction versus salivary secretion, demonstrating that 9b may be useful for the treatment of symptoms associated with overactive bladder without having side effects such as dry mouth.
• Quinuclidine derivatives and medicinal composition thereof
  申请人：Yamanouchi Pharmaceutical Co., Ltd.

  公开号：US06017927A1

  公开（公告）日：2000-01-25

  Quinuclidine derivatives represented by general following general formula (I), salts, N-oxides or quaternary ammonium salts thereof, and medicinal compositions containing the same. ##STR1## The compound has an antagonistic effect on muscarinic M.sub.3 receptors and is useful as a preventive or remedy for urologic diseases, respiratory diseases or digestive diseases.

  由下列通用式（I）表示的喹诺啉衍生物，其盐、N-氧化物或季铵盐，以及含有这些物质的药物组合物。该化合物对毛细血管M.sub.3受体具有拮抗作用，并可用作预防或治疗泌尿系统疾病、呼吸系统疾病或消化系统疾病的药物。